This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cellcentric Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Paul Baguley
Introduction
Paul Baguley is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate p300 and CBP activity. His work holds promise for advancing cancer treatment options.
Latest Patents
Paul Baguley holds a patent for a process titled "Process for preparing modulators of p300 and/or CBP." This innovative process involves treating specific compounds to generate a compound that has potential utility in treating various cancers, including prostate cancer, haematological cancers, bladder cancer, and lung cancer. The compound produced through this process is a promising modulator of p300/CBP activity.
Career Highlights
Baguley is currently associated with Cellcentric Limited, where he continues to work on groundbreaking research. His expertise in the field has led to advancements that could significantly impact cancer therapies.
Collaborations
Throughout his career, Paul Baguley has collaborated with notable colleagues, including David Wood and John Paul Madeley. These collaborations have fostered an environment of innovation and shared knowledge.
Conclusion
Paul Baguley is a distinguished inventor whose work in modulating p300 and CBP activity is paving the way for new cancer treatments. His contributions to the field are invaluable and highlight the importance of innovation in medical research.